Steve M. Sabus serves as Executive at Turning Point Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Steve M. Sabus has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 17, 2022 involved selling 36,667 shares valued at $2.8M.
Steve M. Sabus currently holds 36,667 shares of Turning Point Therapeutics, Inc. (TPTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steve M. Sabus has been a net neutral trader of TPTX stock. They have purchased $0 and sold $0 worth of shares.
Steve M. Sabus's most recent insider trade was on Aug 17, 2022, when they sold 36,667 shares at $76.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |